Advances in Pulmonary Drug Delivery

Area of Science:

• Pulmonary drug delivery
• Pharmacology
• Biomedical engineering

Background:

• Pulmonary drug delivery is a promising non-invasive administration route for both local and systemic treatments.
• Effective delivery requires careful consideration of the drug, its inhalable formulation, and stability.
• The choice of inhaler device and its ability to generate appropriate aerosol particle sizes are critical for targeted lung deposition.

Discussion:

• Patient-specific factors, including respiratory physiology and inhalation technique, significantly impact drug deposition and efficacy.
• This Special Issue highlights advancements in inhalation device testing and aerosol formulation development.
• The integration of in vitro and in silico models aids in understanding pulmonary drug deposition and disposition.

Key Insights:

• Achieving successful pulmonary drug delivery hinges on the synergy between the drug, its formulation, the delivery device, and patient factors.
• Recent research focuses on optimizing inhaler performance and aerosol characteristics for precise drug targeting within the respiratory tract.
• Advanced modeling techniques are crucial for predicting and evaluating drug behavior within the lungs.

Outlook:

• Future directions include the pulmonary delivery of complex therapeutics like vaccines, antibiotics, and peptides.
• Continued innovation in inhalation device technology and formulation science will enhance treatment outcomes.
• Personalized approaches considering patient physiology will further refine pulmonary drug delivery strategies.